SE8703308D0 - Therapeutic agent for the treatment of disorders associated with cerebral ischemia - Google Patents
Therapeutic agent for the treatment of disorders associated with cerebral ischemiaInfo
- Publication number
- SE8703308D0 SE8703308D0 SE8703308A SE8703308A SE8703308D0 SE 8703308 D0 SE8703308 D0 SE 8703308D0 SE 8703308 A SE8703308 A SE 8703308A SE 8703308 A SE8703308 A SE 8703308A SE 8703308 D0 SE8703308 D0 SE 8703308D0
- Authority
- SE
- Sweden
- Prior art keywords
- treatment
- disorders associated
- cerebral ischemia
- therapeutic agent
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19879686 | 1986-08-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8703308D0 true SE8703308D0 (sv) | 1987-08-26 |
SE8703308L SE8703308L (sv) | 1988-02-28 |
SE502323C2 SE502323C2 (sv) | 1995-10-02 |
Family
ID=16397046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8703308A SE502323C2 (sv) | 1986-08-27 | 1987-08-26 | Användning av N-(2-hydroxietyl)nikotinamidnitrat eller ett farmaceutiskt godtagbart salt därav för framställning av ett läkemedel aktivt för behandling av sjukdomar förbundna med cerebral ischemi |
Country Status (22)
Country | Link |
---|---|
US (1) | US4870090A (sv) |
JP (1) | JPH07121863B2 (sv) |
KR (1) | KR950002151B1 (sv) |
AU (1) | AU603375B2 (sv) |
BE (1) | BE1003959A5 (sv) |
CA (1) | CA1302888C (sv) |
CH (1) | CH672069A5 (sv) |
DE (1) | DE3728499A1 (sv) |
DK (1) | DK171392B1 (sv) |
FI (1) | FI873727A (sv) |
FR (1) | FR2605222B1 (sv) |
GB (1) | GB2195532B (sv) |
HK (1) | HK64993A (sv) |
IE (1) | IE60601B1 (sv) |
IT (1) | IT1211477B (sv) |
LU (1) | LU86973A1 (sv) |
NL (1) | NL8701994A (sv) |
NO (1) | NO873571L (sv) |
NZ (1) | NZ221564A (sv) |
SE (1) | SE502323C2 (sv) |
SG (1) | SG52393G (sv) |
ZA (1) | ZA876401B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736529A (en) * | 1996-03-22 | 1998-04-07 | Neurocal International Inc. | Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration |
AU1363699A (en) * | 1997-10-23 | 1999-05-10 | National Institute Of Health | Methods for reducing ischemic injury of the heart via the sequential administ ration of monophosphoryl lipid a and adenosine receptor agents |
WO2000067754A1 (en) | 1999-05-12 | 2000-11-16 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
CN107773545A (zh) * | 2016-08-29 | 2018-03-09 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1562962A (en) * | 1976-04-02 | 1980-03-19 | Chugai Pharmaceutical Co Ltd | Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same |
US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
EP0223811A1 (en) * | 1985-05-22 | 1987-06-03 | Beecham Group Plc | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease |
US4696934A (en) * | 1986-01-10 | 1987-09-29 | Warner-Lambert Company | Method for using nifedipine for treating stroke |
WO1987005508A1 (en) * | 1986-03-14 | 1987-09-24 | Medical College Of Wisconsin Research Foundation, | Method of treatment and prevention of cerebral vasospasms |
-
1987
- 1987-08-19 IE IE221887A patent/IE60601B1/en not_active IP Right Cessation
- 1987-08-21 IT IT8767725A patent/IT1211477B/it active
- 1987-08-21 AU AU77311/87A patent/AU603375B2/en not_active Ceased
- 1987-08-24 US US07/089,044 patent/US4870090A/en not_active Expired - Lifetime
- 1987-08-24 NO NO873571A patent/NO873571L/no unknown
- 1987-08-25 NZ NZ221564A patent/NZ221564A/xx unknown
- 1987-08-25 DK DK441987A patent/DK171392B1/da not_active IP Right Cessation
- 1987-08-26 FR FR878711957A patent/FR2605222B1/fr not_active Expired - Fee Related
- 1987-08-26 SE SE8703308A patent/SE502323C2/sv not_active IP Right Cessation
- 1987-08-26 NL NL8701994A patent/NL8701994A/nl active Search and Examination
- 1987-08-26 DE DE19873728499 patent/DE3728499A1/de not_active Withdrawn
- 1987-08-26 LU LU86973A patent/LU86973A1/fr unknown
- 1987-08-26 KR KR1019870009346A patent/KR950002151B1/ko not_active IP Right Cessation
- 1987-08-26 BE BE8700948A patent/BE1003959A5/fr not_active IP Right Cessation
- 1987-08-26 CA CA000545418A patent/CA1302888C/en not_active Expired - Fee Related
- 1987-08-27 ZA ZA876401A patent/ZA876401B/xx unknown
- 1987-08-27 FI FI873727A patent/FI873727A/fi not_active Application Discontinuation
- 1987-08-27 JP JP62213808A patent/JPH07121863B2/ja not_active Expired - Fee Related
- 1987-08-27 GB GB8720219A patent/GB2195532B/en not_active Expired - Fee Related
- 1987-08-27 CH CH3298/87A patent/CH672069A5/de not_active IP Right Cessation
-
1993
- 1993-04-23 SG SG52393A patent/SG52393G/en unknown
- 1993-07-08 HK HK649/93A patent/HK64993A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1302888C (en) | 1992-06-09 |
NO873571D0 (no) | 1987-08-24 |
NL8701994A (nl) | 1988-03-16 |
GB2195532A (en) | 1988-04-13 |
GB2195532B (en) | 1990-05-23 |
LU86973A1 (fr) | 1987-12-16 |
AU603375B2 (en) | 1990-11-15 |
DE3728499A1 (de) | 1988-03-03 |
KR950002151B1 (ko) | 1995-03-14 |
DK171392B1 (da) | 1996-10-14 |
NZ221564A (en) | 1999-08-30 |
IE60601B1 (en) | 1994-07-27 |
CH672069A5 (sv) | 1989-10-31 |
FR2605222B1 (fr) | 1991-02-22 |
JPS63152317A (ja) | 1988-06-24 |
FI873727A (fi) | 1988-02-28 |
HK64993A (en) | 1993-07-16 |
IT8767725A0 (it) | 1987-08-21 |
FR2605222A1 (fr) | 1988-04-22 |
SE8703308L (sv) | 1988-02-28 |
AU7731187A (en) | 1988-03-03 |
IT1211477B (it) | 1989-11-03 |
BE1003959A5 (fr) | 1992-07-22 |
IE872218L (en) | 1988-02-27 |
KR880002525A (ko) | 1988-05-09 |
SG52393G (en) | 1993-08-06 |
FI873727A0 (fi) | 1987-08-27 |
US4870090A (en) | 1989-09-26 |
DK441987D0 (da) | 1987-08-25 |
DK441987A (da) | 1988-02-28 |
GB8720219D0 (en) | 1987-10-07 |
SE502323C2 (sv) | 1995-10-02 |
NO873571L (no) | 1988-02-29 |
ZA876401B (en) | 1988-04-27 |
JPH07121863B2 (ja) | 1995-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP920667B1 (en) | Application of fultripine active substance for preventing muscle deformation | |
SE7903186L (sv) | Cerebralverksamt medel | |
NO160850C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer. | |
ATE82121T1 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
ES2054723T3 (es) | Tetrahidropiridinoximas, procedimiento para su preparacion y uso de las mismas como agentes colinergicos. | |
DK0520200T3 (da) | Imadazol-forbindelser, deres fremstilling og anvendelse | |
NO885598D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser. | |
NO900697D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater. | |
NO167734C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater. | |
ES2124861T3 (es) | Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa. | |
EP0396748A4 (en) | Agent for treating ischemic brain trouble | |
SE8703308D0 (sv) | Therapeutic agent for the treatment of disorders associated with cerebral ischemia | |
PT86771A (pt) | Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity | |
NO881768D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner. | |
NO881884D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater. | |
DK532087A (da) | Farmaceutiske praeparater til behandling af hjernelidelser paa funktional og organisk basis | |
ZA877454B (en) | Therapeutic agent for the treatment of peptic ulcer disease | |
NO158579C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt n-(2-metoksyetyl)-noroksymorfon. | |
DE68901172D1 (de) | (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend. | |
DK149890C (da) | Analogifremgangsmaade til fremstilling af n-(4-phenyl-2-thiazolyl)-oxamidsyre-2-ethoxyethylester | |
ES2032476T3 (es) | Un procedimiento para preparar nuevos derivados de 2-anilinotiazolina. | |
ES2061775T3 (es) | Derivados de estrobirulina, su obtencion y empleo. | |
NO890245D0 (no) | Isoxazoler med nootrop aktivitet. | |
NO883959L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |